Literature DB >> 24494467

Use of health-related quality-of-life measurements to estimate individuals' health on screening.

L Scalone1, P A Cortesi1, G Spinella2, B Pane2, G Cesana1, L G Mantovani3, D Palombo2.   

Abstract

OBJECTIVES: to investigate the utility of assessing Health-Related Quality of Life (HRQoL) in a large group of subjects participating in a screening program for aneurysm and the relationship between HRQoL, diagnosis of aneurysm and related risk factors.
METHODS: subjects involved in this screening program were submitted the EQ-5D questionnaire to report their own HRQoL. HRQoL was reported also a second time by the subjects who were diagnosed with aneurysm during screening and who returned for a monitoring follow up visit a few months later. We evaluated compliance with HRQoL data collection and performed multiple regression analyses in order to investigate the possible relationship between demographic and clinical data with HRQoL.
RESULTS: 1,633 subjects screened (6.1% diagnosed with aneurysm) and 125 subjects diagnosed with aneurysm and attending a follow-up visit reported their HRQoL. Completion of the EQ-5D questionnaire was well accepted by both physicians and subjects undergoing screening. HRQoL was not significantly different between the screening and followup visits, on adjusting for age and sex. At the screening visit, HRQoL was associated with ASA class, heart condition, BMI and respiratory diseases. No associations were found at the follow-up visit.
CONCLUSION: Assessing HRQoL in screening programs is feasible and well accepted and add useful information on health of large numbers of subjects from general population. This could be considered as a routine approach to optimizing the informative role of screening programs in guiding other investigations or interventions.

Entities:  

Mesh:

Year:  2013        PMID: 24494467

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  1 in total

1.  Impact of abdominal aortic aneurysm screening on quality of life.

Authors:  M F Bath; D Sidloff; A Saratzis; M J Bown
Journal:  Br J Surg       Date:  2018-02       Impact factor: 6.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.